Use of Individualized Starting Dose and Niraparib Hematologic Adverse Event Management Costs in Ovarian Cancer
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH(2025)
Key words
cost management,maintenance therapy,niraparib,ovarian cancer,PARP inhibitor
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined